FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912846952> ?p ?o ?g. }

• W2912846952 endingPage "425" @default.
• W2912846952 startingPage "425" @default.
• W2912846952 abstract "Abstract BACKGROUND: Heparin Induced Thrombocytopenia (HIT) is a potentially devastating antibody-mediated complication of heparin therapy in which autoantibodies activate platelets in the presence of heparin. Despite thrombocytopenia, HIT is strongly associated with thrombosis that can affect the arterial or venous systems. Heparin is generally avoided in patients with a history of HIT; however, it is still the anticoagulant of choice for cardiopulmonary bypass surgery (CPB). Experience with alternative anticoagulants such as direct thrombin inhibitors (DTI) during CPB is limited, and the outcomes of cardiac surgery after a diagnosis of HIT are poorly described. We therefore conducted a retrospective cohort study to compare the 30 day mortality rate, rate of new thromboembolic events and rate of bleeding episodes in patients with a history of HIT who were treated with heparin or DTI undergoing cardiothoracic surgery requiring CPB. METHODS: We identified patients with a history of HIT who underwent cardiothoracic surgery requiring CPB at Cleveland Clinic between 1998 and 2017. We included patients with a history of HIT confirmed by the serotonin release assay. Patients with other prothrombotic disorders were excluded. Demographic and clinical data including details of surgical procedures, anticoagulation, and outcomes (mortality, bleeding, and thrombosis) were collected from the medical record. Bleeding was categorized into minimal (<750 mL), mild (750 ml- 1.5 L), moderate (1.5 L-2 L), and severe (>2 L) bleeding. We evaluated differences in the intraoperative heparin versus DTI groups using the Fisher exact test and T test for categorical and continuous variables, respectively. Associations with study outcomes (mortality, moderate to severe hemorrhage, and thrombotic events) were first evaluated in univariate analyses and then in separate multivariable logistic regression models. RESULTS: Of 13,998 patients that underwent cardiothoracic at Cleveland Clinic between 1998 and 2017, 72 patients had a confirmed prior diagnosis of HIT. Of these, 59 received heparin and 13 received DTI intraoperatively. The heparin and DTI groups were not different in terms of age (69 versus 65, P=0.102), presence of thrombocytopenia (39.0% vs. 30.8%, P=0.580), time on CPB (P=0.376), heparin-PF4 ELISA optical density (P=0.336), or surgery type (P=0.820).Thirty day mortality was 8.5% and 0% in the heparin and DTI groups, respectively (P=0.277). Thrombotic events occurred in 15 (25.4%) of the patients on heparin and 1 (7.7%) on DTI (P= 0.164). Of the 72 patients, 23 (31.9%) experienced minimal bleeding, 19 (26.4%) experienced mild bleeding, 26 (31.6%) experienced moderate bleeding and 4 (5.6%) experienced severe bleeding. In the heparin group, 16 (27.1%) had minimal bleeding, 14 (23.7%) had mild bleeding, while 25 (42.4%) had moderate bleeding and 4 (6.8%) had severe bleeding. In the DTI group, 7 (53.8%) had minimal bleeding, 5 (38.5%) had mild bleeding, while 1 (7.8%) had moderate bleeding and 0 had severe bleeding. The anticoagulant used intraoperatively was not associated with mortality or thrombosis in multivariable logistic regression models adjusted for gender, and ELISA optical density. To identify associations with bleeding, we categorized bleeding as minimal to mild (class I-II) and moderate to severe (class III -IV). The type of anticoagulant (DTI versus heparin) was significantly associated with moderate to severe hemorrhage (OR 0.080 [95% CI 0.011-0.731], P=0.024) when adjusted for the presence of thrombocytopenia (OR 0.945 [95% CI 0.332-2.690], P=0.915), and time on CPB (2-4 hours, OR 2.74 [95% CI 0.24-31.89], P=0.421), and (>4 hours, OR 3.36 [95% CI 0.32-35.60], P=0.313). CONCLUSION: For patients with a prior diagnosis of HIT that undergo subsequent cardiothoracic surgery requiring CPB, intraoperative use of DTI versus heparin is associated with a lower rate of moderate to severe hemorrhage (7.7% vs 49.2%, P=0.006) and may be associated with lower rates of 30-day mortality (0% vs 8.5%, P=0.277), and thrombosis (7.7% vs 25.4%, P=0.164). While the differences in mortality and thrombosis rates did not reach statistical significance in our small sample size, these results are concerning and indicate a need for further investigation, ideally in randomized multicenter trials. Disclosures No relevant conflicts of interest to declare." @default.
• W2912846952 created "2019-02-21" @default.
• W2912846952 creator A5035031332 @default.
• W2912846952 creator A5047512989 @default.
• W2912846952 creator A5054333442 @default.
• W2912846952 date "2018-11-29" @default.
• W2912846952 modified "2023-09-29" @default.
• W2912846952 title "Heparin Vs Direct Thrombin Inhibitors in Patients with Previous HIT Undergoing Cardiothoracic Surgery: The Cleveland Clinic Experience" @default.
• W2912846952 doi "https://doi.org/10.1182/blood-2018-99-115375" @default.
• W2912846952 hasPublicationYear "2018" @default.
• W2912846952 type Work @default.
• W2912846952 sameAs 2912846952 @default.
• W2912846952 citedByCount "0" @default.
• W2912846952 crossrefType "journal-article" @default.
• W2912846952 hasAuthorship W2912846952A5035031332 @default.
• W2912846952 hasAuthorship W2912846952A5047512989 @default.
• W2912846952 hasAuthorship W2912846952A5054333442 @default.
• W2912846952 hasConcept C141071460 @default.
• W2912846952 hasConcept C2776472838 @default.
• W2912846952 hasConcept C2777557582 @default.
• W2912846952 hasConcept C2778205648 @default.
• W2912846952 hasConcept C2778789114 @default.
• W2912846952 hasConcept C2780868729 @default.
• W2912846952 hasConcept C42219234 @default.
• W2912846952 hasConcept C71924100 @default.
• W2912846952 hasConceptScore W2912846952C141071460 @default.
• W2912846952 hasConceptScore W2912846952C2776472838 @default.
• W2912846952 hasConceptScore W2912846952C2777557582 @default.
• W2912846952 hasConceptScore W2912846952C2778205648 @default.
• W2912846952 hasConceptScore W2912846952C2778789114 @default.
• W2912846952 hasConceptScore W2912846952C2780868729 @default.
• W2912846952 hasConceptScore W2912846952C42219234 @default.
• W2912846952 hasConceptScore W2912846952C71924100 @default.
• W2912846952 hasIssue "Supplement 1" @default.
• W2912846952 hasLocation W29128469521 @default.
• W2912846952 hasOpenAccess W2912846952 @default.
• W2912846952 hasPrimaryLocation W29128469521 @default.
• W2912846952 hasRelatedWork W2051150654 @default.
• W2912846952 hasRelatedWork W2071655951 @default.
• W2912846952 hasRelatedWork W2076315269 @default.
• W2912846952 hasRelatedWork W2149792950 @default.
• W2912846952 hasRelatedWork W2410181902 @default.
• W2912846952 hasRelatedWork W2416622845 @default.
• W2912846952 hasRelatedWork W2418664300 @default.
• W2912846952 hasRelatedWork W2790916719 @default.
• W2912846952 hasRelatedWork W3082119373 @default.
• W2912846952 hasRelatedWork W4232000912 @default.
• W2912846952 hasVolume "132" @default.
• W2912846952 isParatext "false" @default.
• W2912846952 isRetracted "false" @default.
• W2912846952 magId "2912846952" @default.
• W2912846952 workType "article" @default.